Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYUREA vs IBRITUMOMAB TIUXETAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HYDROXYUREA vs IBRITUMOMAB TIUXETAN: Safety Overview

Metric HYDROXYUREA IBRITUMOMAB TIUXETAN
Total FAERS Reports 5,966 605
Deaths Reported 664 248
Death Rate 11.1% 41.0%
Hospitalizations 2,103 181
Average Patient Age 58.7 yrs 59.9 yrs
% Female Patients 51.1% 34.8%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Endo USA, Inc. Acrotech Biopharma Inc
Route ORAL N/A
Marketing Status Prescription Prescription